ECP safely lowers IOP before cataract surgery


Dr Randolph Evans argues that endocyclophotocoagulation (ECP) is a simple, safe and effective procedure for achieving IOP lowering in patients with medically controlled glaucoma who also require cataract surgery

Endocyclophotocoagulation (ECP) is a simple, safe, and effective procedure for achieving IOP lowering in patients who have medically controlled glaucoma and need cataract surgery, said Randolph R. Evans, MD, at the Nashville Academy of Ophthalmology meeting.

Laser energy is applied to the ciliary processes to destroy ciliary epithelial cells that produce aqueous humour.

450 eyes

Dr Evans reported that, over the past 5 years, he and his practice partner, Bill Schenk, MD, have performed ECP combined with phacoemulsification in about 450 eyes with excellent results that mirror outcomes reported by others, including Stanley Berke, MD.

Dr Berke and colleagues evaluated ECP in a large, randomized control trial that included 626 patients who underwent phaco plus ECP and 81 patients who had phaco alone. After a mean follow-up of about 3 years, the patients who had the combined procedure benefited with a 3 mm Hg IOP reduction from baseline and were using, on average, one less medication than before surgery. In the control group, IOP decreased initially but began to increase over time.

At the end of follow-up, mean IOP in the phaco-only group exceeded the baseline value, and these patients had no change in their medication use.

Related Videos
Fritz Hengerer, MD, PhD, Director, Eye Hospital at Bürgerhospital, Frankfurt, Germany
Dr Sheng Lim, professor of glaucoma studies at St Thomas' Hospital, London
Kasperi Kankare at the iCare booth at ESCRS
Disrupting the glaucoma treatment paradigm with novel femtosecond laser from ViaLase
2-year data in contralateral eye evaluation gives edge to iStent inject over Hydrus stent
Should endocyclophotocoagulation be considered part of MIGS? Mr Ratnarajan delves in
Investigating the effects of canaloplasty on corneal epithelium
© 2023 MJH Life Sciences

All rights reserved.